CHEK1 and lymphoma: To identify the biologic features determining the highest sensitivity to Chk1 inhibition in lymphomas, we compared the baseline gene expression profiling of 21 of the most sensitive cell lines to PF-00477736 (IC50 < 25 nM) versus the five most resistant cell lines (IC50 > 150 nM).